The Swiss government said on Thursday a U.S. announcement to support waiving intellectual property rights for COVID-19 vaccines was a significant announcement but left many questions unanswered. “This is an important announcement by the U.S., but many questions remain unanswered about the specific solutions it is considering in this context,”[Read More…]